p53 in recombination and repair

Cell Death and Differentiation

Volumn 13, Issue 6, 2006, Pages 1003-1016

  Gatz, S A ^a   Wiesmüller, Lisa ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Excision repair; Homologous recombination; Mismatch repair; Nonhomologous end joining; Topoisomerase I

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA TOPOISOMERASE; DOUBLE STRANDED RNA; GENE PRODUCT; PROTEIN 14 3 3; PROTEIN MSH2; PROTEIN P53; RAD51 PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL GROWTH; CHROMOSOME ABERRATION; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; FAMILIAL CANCER; GENE MUTATION; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC STABILITY; GENETIC TRANSCRIPTION; GROWTH REGULATION; HOMOLOGOUS RECOMBINATION; HUMAN; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MISMATCH REPAIR; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SARCOMA; TARGET CELL; TRANSACTIVATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; HUMANS; MUTATION; RECOMBINATION, GENETIC; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644927601     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401903     Document Type: Review

References (174)

1. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53.
2. deFromentel C and Soussi T (1992) TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosomes Cancer 4: 1-15.
3. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16.
4. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
5. Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace Jr AJ, Appelia E and Anderson CW (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278: 37536-37544.
6. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG and Benchimol S (1997) ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 16: 6018-6033.
7. Wang X, Ohnishi K, Takahashi A and Ohnishi T (1998) Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene 17: 2819-2825.
8. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wildtype p53. Cell 70: 923-935.
9. Harvey M, Sands AT, Weiss AS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467.
10. Ishizaki K, Ejima Y, Matsunaga T, Hara R, Sakamoto A, Ikenaga M, Ikawa Y and Aizawa S (1994) Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int. J. Cancer 58: 254-257.
11. Schwartz JL and Russell KJ (1999) The effect of functional inactivation of TP53 by HPV-E6 transformation on the induction of chromosome aberrations by gamma rays in human tumor cells. Radiat. Res. 151: 385-390.
12. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Wameford SG, Dalla-Pozza L and Reddel RR (1995) Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15: 4745-4753.
13. Bakalkin G, Yakovleva T, Selivanova G, Magnusson KP, Szekely L, Kiseleva E, Klein G, Terenius L and Wiman KG (1994) P53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91: 413-417.
14. Jayaraman J and Prives C (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029.
15. Lee S, Elenbaas B, Levine A and Griffith J (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/ deletion mismatches. Cell 81: 1013-1020.
16. Reed M, Woelker B, Wang P, Wang Y, Anderson ME and Tegtmeyer P (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92: 9455-9459.
17. Oberosler P, Hloch P, Ramsperger U and Stahl H (1993) p53-catalyzed annealing of complementary single-stranded nucleic adds. EMBO J. 12: 2389-2396.
18. Brain R and Jenkins JR (1994) Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP. Oncogene 9: 1775-1780.
19. Jean D, Gendron D, Delbecchi L and Bourgaux P (1997) p53-mediated DNA renaturation can mimic strand exchange. Nucleic Acids Res. 25: 4004-4012.
20. Lee S, Cavallo L and Griffith J (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272: 7532-7539.
21. Dudenhöffer C, Kurth M, Janus F, Deppert W and Wiesmüller L (1998) Dissociation of the recombination control and the sequence-specific transactivation function of p53. Mol. Cell. Biol. 18: 5332-5342.
22. Janz C, Süsse S and Wiesmüller L (2002) p53 and recombination intermediates: Role of tetramerization at DNA junctions in complex formation and exonucleolytic degradation. Oncogene 21: 2130-2140.
23. Mummenbrauer T, Janus F, Müller B, Wiesmüller L, Deppert W and Grosse F (1996) P53 exhibits 3′-′to 5′-exonuclease activity. Cell 85: 1089-1099.
24. Huang P (1998) Excision of mismatched nucleotides from DNA: A potential mechanism for enhancing DNA replication fidelity by the wildtype p53 protein. Oncogene 17: 261-270.
25. Janus F, Albrechtsen N, Knippschild U, Wiesmüller L, Grosse F and Deppert W (1999) Different regulation of the core domain activities 3′ to 5′ exonuclease and sequence-specific DNA binding. Mol. Cell. Biol. 19: 2155-2168.
26. Skalski V, Lin ZY, Choi BY and Brown KR (2000) Substrate specificity of the p53-associated 3′-5′ exonuclease. Oncogene 19: 3321-3329.
27. Bakhanashvili M (2001) Exonucleolytic proofreading by p53 protein. Eur. J. Biochem. 268: 2047-2054.
28. Shakked Z, Yavnilovitch M, Kalb Gilboa AJ, Kessler N, Wolkowicz R, Rotter V and Haran TE (2002) DNA binding and 3′-5′ exonuclease activity in the murine alternatively-spliced p53 protein. Oncogene 21: 5117-5126.
29. Melle C and Nasheuer HP (2002) Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase. Nucleic Acids Res. 30: 1493-1499.
30. Dudenhöffer C, Rohaly G, Will K, Deppert W and Wiesmüller L (1999) Dissociation of the recombination control and the sequence-specific transactivation function of p53. Oncogene 18: 5773-5784.
31. Albrechtsen N, Domreiter I, Grosse F, Kim E, Wiesmuller L and Deppert W (1999) Maintenance of genomic integrity by p53: Complementary roles for activated and non-activated p53. Oncogene 18: 7706-7717.
32. Bertrand P, Saintigny Y and Lopez BS (2004) P53's double life: transactivation-independent repression of homologous recombination. Trends Genet. 20: 235-243.
33. Sengupta S and Harris CC (2005) p53: Traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6: 44-55.
34. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH and Levine AJ (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14: 981-993.
35. Vogelstein B, Lane D and Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310.
36. Nakano K and Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7: 683-694.
37. Baptiste N and Prives C (2004) p53 in the cytoplasm: A question of overkill? Cell 116: 487-489.
38. Hoeijmakers JHJ (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-373.
39. Schärer OD (2003) Chemistry and biology of DNA repair. Angew. Chem. Int. Ed. Engl. 42: 2946-2974.
40. Ford JM and Hanawalt PC (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA 92: 8876-8880.
41. Zhu Q, Wani MA, El-Mahdy M and Wani AA (2000) Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand. J. Biol. Chem. 275: 11492-11497.
42. Huang BJ, Ford JM, Hanawalt PC and Chu G (1999) Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA 96: 424-428.
43. Adimoolam S and Ford JM (2002) p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA 99: 12985-12990.
44. Tan T and Chu G (2002) p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol. Cell. Biol. 22: 3247-3254.
45. Amundson SA, Patterson A, Do KT and Fornace Jr AJ (2002) A nucleotide excision repair master-switch: P53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 1: 145-149.
46. McKay BC, Ljungman M and Rainbow AJ (1999) Potential roles for p53 in nucleotide excision repair. Carcinogenesis 20: 1389-1396.
47. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380.
48. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace Jr AJ (2000) p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and/ or gadd45 genes. Mol. Cell. Biol. 20: 3705-3714.
49. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42-49.
50. MacLachlan TK, Takimoto R and El-Deiry WS (2002) BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol. Cell. Biol. 22: 4280-4292.
51. Adimoolam S and Ford JM (2003) p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair 2: 947-954.
52. Ouchi T, Monteiro AN, August A, Aaronson SA and Hanafusa H (1998) BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95: 2302-2306.
53. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182.
54. Rafferty JA, Clarke AR, Sellappan D, Koref MS, Frayling IM and Margison GP (1996) Induction of murine O6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. Oncogene 12: 693-697.
55. Grombacher T, Eichhorn U and Kaina B (1998) p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 17: 845-851.
56. Barnes DE and Lindahl T (2004) Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38: 445-476.
57. Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC and Rotter V (2004) The role of p53 in base excision repair following genotoxic stress. Carcinogenesis 25: 11-19.
58. Lu X, Nguyen TA, Appella E and Donehower LA (2004) Homeostatic regulation of base excision repair by a p53-induced phosphatase: Linking stress response pathways with DNA repair proteins. Cell Cycle 3: 1363-1366.
59. Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C and Schartl M (2000) p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J. Biol. Chem. 275: 37469-37473.
60. Warnick CT, Dabbas B, Ford CD and Strait KA (2001) Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J. Biol. Chem. 276: 27363-27370.
61. Chen J and Sadowski I (2005) Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc. Natl. Acad. Sci. USA 102: 4813-4818.
62. Evans E and Alani E (2000) Roles for mismatch repair factors in regulating genetic recombination. Mol. Cell. Biol. 20: 7839-7844.
63. Marti TM, Kunz C and Fleck O (2002) DNA mismatch repair and mutation avoidance pathways. J. Cell. Physiol. 191: 28-41.
64. Jiricny J and Nyström-Lahti M (2000) Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 10: 157-161.
65. Stojic L, Brun R and Jiricny J (2004) Mismatch repair and DNA damage signalling. DNA Repair 3: 1091-1101.
66. Liebetrau W, Budde A, Savoia A, Grummt F and Hoehn H (1997) p53 activates Fanconi anemia group C gene expression. Hum. Mol. Genet. 6: 277-283.
67. Myung K, Braastad C, He DM and Hendrickson E (1998) KARP-1 is induced by DNA damage in a p53- and ataxia telangiectasia mutated-dependent fashion. Proc. Natl. Acad. Sci. USA 95: 7664-7669.
68. Smith ML, Chen IT, Zhan Q, O'Connor PM and Fornace Jr AJ (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10: 1053-1059.
69. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10: 188-195.
70. Leveillard T, Andera L, Bissonnette N, Schaeffer L, Bracco L, Egly JM and Wasylyk B (1996) Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 15: 1615-1624.
71. Rubbi CP and Milner J (2003) p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J. 22: 975-986.
72. Offer H, Wolkowicz R, Mates D, Blumenstein S, Livneh Z and Rotter V (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett. 450: 197-204.
73. Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC and Rotter V (2001) Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene 20: 581-589.
74. Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N and Rotter V (2002) The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 23: 1025-1032.
75. Zhou J, Ahn J, Wilson SH and Prives C (2001) A role for p53 in base excision repair. EMBO J. 20: 914-923.
76. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S and Prives C (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11: 558-570.
77. Gaiddon C, Moorthy NC and Prives C (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J. 18: 5609-5621.
78. Seemann S and Hainaut P (2005) Roles of thioredoxin reductase 1 and APE/ Ref-1 in the control of basal p53 stability and activity. Oncogene 24: 3853-3863.
79. Seo YR, Fishel ML, Amundson S, Kelley MR and Smith ML (2002) Implication of p53 in base excision DNA repair: In vivo evidence. Oncogene 21: 731-737.
80. Sobol RW, Kartalou M, Almeida KH, Joyce DF, Engelward BP, Horton JK, Prasad R, Samson LD and Wilson SH (2003) Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J. Biol. Chem. 278: 39951-39959.
81. de Souza-Pinto NC, Harris CC and Bohr VA (2004) p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 23: 6559-6568.
82. Robles AI, Wang XW and Harris CC (1999) Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: Possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene 18: 4681-4688.
83. Ljungman M and Lane DP (2004) Transcription - guarding the genome by sensing DNA damage. Nat. Rev. Cancer 4: 727-737.
84. Miller SD, Moses K, Jayaraman L and Prives C (1997) Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA. Mol. Cell. Biol. 17: 2194-2201.
85. Abramova NA, Russell J, Botchan M and Li R (1997) Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner. Proc. Natl. Acad. Sci. USA 94: 7186-7191.
86. Valerie K and Povirk LF (2003) Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22: 5792-5812.
87. Lees-Miller SP and Meek K (2003) Repair of DNA double strand breaks by non-homologous end joining. Biochimie 85: 1161-1173.
88. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, Parker AR, Jackson SP, Gennery A, Jeggo PA and Löbrich M (2004) A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 16: 715-724.
89. Petrini JHJ and Strecker TH (2003) The cellular response to DNA double-strand breaks: Defining the sensors and mediators. Trends Cell Biol. 13: 458-462.
90. Assenmacher N and Hopfner KP (2004) MRE11/RAD50/NBS1: Complex activities. Chromosome 113: 157-166.
91. Paull TT and Lee JH (2005) The Mre11/Rad50/Nbs1 complex and its role as a DNA double-strand break sensor for ATM. Cell Cycle 4: 737-740.
92. Krejci L, Chen L, Van Komen S, Sung P and Tomkinson A (2003) Mending the break: Two DNA double-strand break repair machines in eukaryotes. Nucleic Acids Res. Mol. Biol. 74: 159-201.
93. Stark JM, Pierce AJ, Oh J, Pastink A and Jasin M (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol. Cell. Biol. 24: 9305-9316.
94. Rothkamm K, Krüger I, Thompson LT and Löbrich M (2003) Pathways of DNA double-strand break repair during mammalian cell cycle. Mol. Cell. Biol. 23: 5706-5715.
95. Morris SM (2002) A role for p53 in the frequency and mechanism of mutation. Mutat. Res. 511: 45-62.
96. Xia F, Amundson SA, Nickoloff JA and Liber HL (1994) Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation. Mol. Cell. Biol. 14: 5850-5857.
97. Liang L, Shao C, Deng L, Mendonca MS, Stambrook PJ and Tischfield JA (2002) Radiation-induced genetic instability in vivo depends on p53 status. Mutat. Res. 502: 69-80.
98. Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN and Jerry DJ (2004) Loss of heterozygosity occurs via mitotic recombination in Trp53+/-mice and associates with mammary tumor susceptibility of the BALB/c strain. Cancer Res. 64: 5140-5147.
99. Bishop AJ, Hollander MC, Kosaras B, Sidman RL, Fornace Jr AJ and Schiestl RH (2003) Atm-, p53-, Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development. Cancer Res. 63: 5335-5343.
100. Rotter V, Schwartz D, Almon E, Goldfinger N, Kapon A, Meshorer A, Donehower LA and Levine AJ (1993) Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. USA 90: 9075-9079.
101. Gersten KM and Kemp CJ (1997) Normal meiotic recombination in p53-deficient mice. Nature Genet. 17: 378-379.
102. Wiesmüller L, Cammenga J and Deppert W (1996) In vivo assay of p53 function in homologous recombination between Simian Virus 40 chromosomes. J. Virol. 70: 737-744.
103. Willers H, Xia F and Powell SN (2002) Recombinational DNA repair in cancer and normal cells: The challenge of functional analysis. J. Biomed. Biotechnol. 2: 86-93.
104. Akyüz N, Boehden GS, Süsse S, Rimek A, Preuss U, Scheidtmann KH and Wiesmüller L (2002) DNA substrate dependence of p53 mediated regulation of double-strand break repair. Mol. Cell. Biol. 22: 6306-6317.
105. Sengupta S, Linke SP and Pedeux R (2003) BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J. 22: 1210-1222.
106. Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T and Lopez BS (1997) Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14: 1117-1122.
107. Mekeel KL, Tang W, Kachnik LA, Luo CM, DeFrank JS and Powell SN (1997) Inactivation of p53 results in high rates of homologous recombination. Oncogene 14: 1847-1857.
108. Saintigny Y, Rouillard D, Chaput B, Soussi T and Lopez BS (1999) Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 18: 3553-3565.
109. Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F and Powell SN (2000) Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 19: 632-639.
110. Boehden GS, Akyüz N, Roemer K and Wiesmüller L (2003) p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene 22: 4111-4117.
111. Willers H, McCarthy EE, Hubb P, Dahm-Daphi J and Powell SN (2001) Homologous recombination in extrachromosomal plasmid substrates is not suppressed by p53. Carcinogenesis 22: 1757-1763.
112. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth W, Yang Q, Garfield SH, Stürzbecher HW and Harris CC (2003) P53 interacts with hRad51 and hRad54, and directly modulates homologous recombination. Cancer Res. 63: 2596-2605.
113. Saintigny Y, Delacote YF, Vares G, Petitot F, Lambert S, Averbeck D and Lopez BS (2001) Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J. 20: 3861-3870.
114. Rothstein R, Michel B and Gangloff S (2000) Replication fork pausing and recombination or 'gimme a break'. Genes Dev. 14: 1-10.
115. Saintigny Y and Lopez BS (2002) Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. Oncogene 21: 488-492.
116. Janz C and Wiesmüller L (2002) Wildtype p53 inhibits replication-associated homologous recombination. Oncogene 21: 5229-5933.
117. Paulson TG, Almasan A, Brody LL and Wahl GM (1998) Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol. Cell. Biol. 18: 3089-3100.
118. Kumari A, Schultz N and Helleday T (2004) p53 protects from replication-associated DNA double-strand breaks in mammalian cells. Oncogene 23: 2324-2329.
119. Squires S, Coates JA, Goldberg M, Toji LH, Jackson SP, Clarke DJ and Johnson RT (2004) p53 prevents the accumulation of double-strand DNA breaks at stalled-replication forks induced by UV in human cells. Cell Cycle 3: 1543-1557.
120. Zink D, Mayr C, Janz C and Wiesmüller L (2002) Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene 21: 4788-4800.
121. Restle A, Janz C and Wiesmuller L (2005) Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination. Oncogene 24: 4367-4380.
122. Gottifredi V, Shieh S, Taya Y and Prives C (2001) p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc. Natl. Acad. Sci. USA 98: 1036-1041.
123. Stürzbecher HW, Donzelmann B, Henning W, Knippschild U and Buchhop S (1996) p53 is linked directly to homologous recombination processes via Rad51/RecA protein interaction. EMBO J. 15: 1992-2002.
124. Buchhop S, Gibson MK, Wang XY, Wagner P, Stürzbecher HW and Harris CC (1997) Interaction of p53 with the human Rad51 protein. Nucleic Acids Res. 25: 3868-3874.
125. Süsse S, Janz C, Janus F, Deppert W and Wiesmüller L (2000) Role of heteroduplex joints in the functional interactions between human Rad51 and wildtype p53. Oncogene 19: 4500-4512.
126. Zhang H, Somasundram K, Pang Y, Tian H, Zhang H, Bi D, Weber BL and El-Deiry WS (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713-1721.
127. Marmorstein LY, Ouchi T and Aaronson SA (1998) The BRCA2 gene product functionally interacts with p53 and Rad51. Proc. Natl. Acad. Sci. USA 95: 13869-13874.
128. Jasin M (2002) Homologous repair of DNA damage and tumourigenesis: The BRCA connection. Oncogene 21: 8981-8993.
129. Romanova LY, Willers H, Blagosklonny MV and Powell SN (2004) The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 23: 9025-9033.
130. Blander G, Kipnis J, Leal JFM, Yu CE, Schellenberg GD and Oren M (1999) Physical and functional interaction between p53 and Werner's syndrome protein. J. Biol. Chem. 274: 29463-29469.
131. Wang XW, Tseng A, Ellis NA, Spillare EA, Linke SP, Robles AI, Seker H, Yang Q, Hu P, Beresten S, Bemmels NA, Garfield S and Harris CC (2001) Functional interaction of p53 and BLM DNA helicase in apoptosis. J. Biol. Chem. 276: 32948-32955.
132. Yang Q, Zhang R, Wang XW, Spillare EA, Linke SP, Subramanian D, Griffith JD, Li JL, Hickson ID, Shen JC, Loeb LA, Mazur SJ, Appella E, Brosh Jr RM, Karamakar P, Bohr VA and Harris CC (2002) The processing of the Holliday junctions by BLM and WRN helicases is regulated by p53. J. Biol. Chem. 277: 31980-31987.
133. Yoon D, Wang Y, Stapleford K, Wiesmüller L and Chen J (2004) p53 inhibits strand exchange and replication fork regression promoted by human Rad51. J. Mol. Biol. 336: 639-654.
134. Yun S, Lie-A-Cheong C and Porter AC (2004) Discriminatory suppression of homologous recombination by p53. Nucleic Acids Res. 32: 6479-6489.
135. Prabhu VP, Simons AM, Iwasaki H, Gai D, Simmons DT and Chen J (2002) p53 blocks RuvAB promoted branch migration and modulates resolution of Holliday junctions by RuvC. J. Mol. Biol. 316: 1023-1032.
136. Degtyareva N, Subramanian D and Griffith JD (2001) Analysis of the binding of p53 to DNAs containing mismatched and bulged bases. J. Biol. Chem. 276: 8778-8784.
137. Alani E, Lee S, Kane MF, Griffith J and Kolodner RD (1997) Saccharomyces cerevisiae MSH2, a mispaired base recognition protein, also recognizes Holliday junctions in DNA. J. Mol. Biol. 265: 289-301.
138. Elliott B and Jasin M (2001) Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol. Cell. Biol. 21: 2671-2682.
139. Yang Q, Zhang R, Wang XW, Linke SP, Sengupta S, Hickson ID, Pedrazzi G, Perrera C, Stagljar I, Littman SJ, Modrich P and Harris CC (2004) The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase. Oncogene 23: 3749-3756.
140. Subramanian D and Griffith JD (2002) Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res. 30: 2427-2434.
141. Subramanian D and Griffith JD (2005) Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events. Biochemistry 44: 2536-2544.
142. Sommers JA, Sharma S, Doherty KM, Karmakar P, Yang Q, Kenny MK, Harris CC and Brosh Jr RM (2005) p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res 65: 1223-1233.
143. Bachrati CZ and Hickson ID (2003) RecQ helicases: Suppressors of tumourigenesis and premature aging. Biochem. J. 374: 577-606.
144. Sengupta S, Robles AI, Linke SP, Sinogeeva NI, Zhang R, Pedeux R, Ward IM, Celeste A, Nussenzweig A, Chen J, Halazonetis TO and Harris CC (2004) Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J. Cell Biol. 166: 801-813.
145. Davalos AR, Kaminker P, Hansen RK and Campisi J (2004) ATR and ATM-dependent movement of BLM helicase during replication stress ensures optimal ATM activation and 53BP1 focus formation. Cell Cycle 3: 1579-1586.
146. Yang T, Namba H, Takmura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K and Yamashita S (1997) p53 induced by ionizing radiation mediates DNA end-joining activity, but not apoptosis of thyroid cells. Oncogene 14: 1511-1519.
147. Tang W, Willers H and Powell SN (1999) p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts. Cancer Res. 59: 2562-2565.
148. Bill CA, Yu Y, Miselis NR, Little JB and Nickoloff JA (1997) A role for p53 in DNA end rejoining by human cell extracts. Mutat Res. 385: 21-29.
149. Lee H, Sun D, Larner JM and Wu FS (1999) The tumor suppressor p53 can reduce stable transfection in the presence of irradiation. J. Biomed. Sci. 6: 285-292.
150. Okorokov AL, Warnock L and Milner J (2002) Effect of wildtype, S15D and R175H p53 proteins on DNA end-joining in vitro: Potential mechanism of DNA double-strand break repair modulation. Carcinogenesis 23: 549-557.
151. Dahm-Daphi J, Hubbe P, Horvath F, El-Awady RA, Bouffard KE, Powell SN and Willers H (2005) Nonhomologous end-joining of site-specific but not of radiation-induced DNA double-strand breaks is reduced in the presence of wildtype p53. Oncogene 24: 1663-1672.
152. Bristow RG, Hu Q, Jang A, Chung S, Peacock J, Benchimol S and Hill R (1998) Radioresistant MTp53-expressing rat embryo transformants exhibit increased DNA dsb rejoining during exposure to ionising radiation. Oncogene 16: 1789-1802.
153. Lin Y, Waldman BC and Waldman AS (2003) Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin-alpha, a chemical inhibitor of p53. DNA Repair 2: 1-11.
154. Zotchev SB, Protopopova M and Selivanova G (2000) p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core. Nucleic Acids Res. 28: 4005-4012.
155. Vukojevic V, Yakovleva T, Terenius L, Pramanik A and Bakalkin G (2004) Denaturation of dsDNA by p53: Fluorescence correlation spectroscopy study. Biochem. Biophys. Res. Commun. 316: 1150-1155.
156. Gaymes TJ, North PS, Brady N, Hickson ID, Mufti GJ and Rassool FV (2002) Increased error-prone non homologous DNA end-joining - a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene 21: 2525-2533.
157. Boehden GS, Restle A, Marschalek R, Stocking C and Wiesmüller L (2004) Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53. Carcinogenesis 25: 1-9.
158. Albor A, Kaku S and Kulesz-Martin M (1998) Wildtype and mutant forms of p53 activate human topoisomerase I: A possible mechanism for gain of function in mutants. Cancer Res. 5: 2091-2094.
159. Gobert C, Skladanowski A and Larsen AK (1999) The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wildtype and mutant p53. Proc. Natl. Acad. Sci. USA 96: 10355-10360.
160. Soe K, Hartmann H, Schlott B, Stevnsner T and Grosse F (2002) The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro. Oncogene 21: 6614-6623.
161. Aubrecht J, Secretan MB, Bishop AJ and Schiestl RH (1999) Involvement of p53 in X-ray induced intrachromosomal recombination in mice. Carcinogenesis 20: 2229-2236.
162. Boehden GS, Baumann C, Siehler S and Wiesmüller L (2005) Wildtype p53 stimulates homologous recombination upon sequence-specific binding to ribosomal gene cluster repeat. Oncogene 24: 4183-4192.
163. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252: 1708-1711.
164. Brazdova M, Palecek J, Cherny DI, Billova S, Fojta M, Pecinka P, Vojtesek B, Jovin TM and Palecek E (2002) Role of tumor suppressor p53 domains in selective binding to supercoiled DNA. Nucleic Acids Res. 30: 4966-4974.
165. Donehower LA, Harvey M, Slagle BL, MacArthur MJ, Montgomery CA, Butel JS and Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
166. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P (1995) Mice lacking p21 cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
167. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737.
168. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM and Lowe SW (2002) Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1: 289-298.
169. Ceballos E, Delgado MD, Gutierrez P, Richard C, Muller D, Eilers M, Ehinger M, Gullberg U and Leon J (2000) c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene 19: 2194-2204.
170. Soussi T, Leblanc T, Baruchel A and Schaison G (1993) Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: A review. Nouv. Rev. Fr. Hematol. 35: 33-36.
171. Thompson LH and Schild D (2002) Recombinational DNA repair and human disease. Mutat. Res. 509: 49-78.
172. Gebow D, Miselis N and Liber HL (2000) Homologous and nonhomologous recombination resulting in deletion: Effects of p53 status, microhomology and repetitive DNA length and orientation. Mol. Cell. Biol. 20: 4028-4035.
173. Lu X, Lozano G and Donehower LA (2003) Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat. Res. 522: 69-83.
174. Meek DW (2004) The p53 response to DNA damage. DNA Repair 3: 1049-1056.